LAMA-LABAs were associated with a lower hazard of first moderate or severe COPD exacerbation (HR, 0.91; 95% CI, 0.86-0.96) and a lower hazard of first pneumonia hospitalization (HR, 0.75; 95% CI, 0.69-0.83) compared with Advair Diskus and a lower hazard of first moderate or severe COPD...
Food & Drug Administration (FDA) has warned consumers, pharmacists, and wholesalers against using stolen Diskus inhalers of Advair. Advair Diskus (fluticasone propionate and salmeterol inhalation powder) is an inhaler used to treat patients with asthma and chronic obstructive pulmonary disease.U.S ...
Use of dry powder inhalers (DPIs) for the treatment of chronic respiratory disease has increased considerably in recent years (1). DPI devices generally fall into three categories, single-unit dose devices, multi-dose reservoir devices and multiple-unit dose devices (1). Diskus® or Accuhaler...
Pharmacokinetic Bioequivalence of Two Fluticasone Propionate/Salmeterol Dry Powder Inhalers, OT329 Solis, and Advair Diskusdoi:10.1016/j.chest.2017.08.799EliseBurmeisterGetzKevinCarrollSDOSChest
With that said, generic competition with these DPIs is expected to lead to reduced costs for the patient, which has been reported following the introduction of the first Advair Diskus generic [121]. As this new area continues to develop and bring with it new regulatory challenges, the FDA ...